Gilead (GILD) CEO Daniel O'Day Sells 15,000 Shares

What Happened
Daniel Patrick O'Day, Chairman & CEO of Gilead Sciences (GILD), disposed of 15,000 shares in open-market sales on August 3, 2026. The filing reports three transactions: 6,700 shares at $129.66 ($868,711), 7,700 shares at $130.80 ($1,007,177), and 600 shares at $131.34 ($78,806), for total gross proceeds of approximately $1,954,694. These were sales (not purchases) and are typically treated as routine insider selling.

Key Details

• Transaction date: 2026-08-03; Form 4 filed: 2026-08-04 (appears timely).
• Reported per-line sales and proceeds: 6,700 @ $129.66 ($868,711); 7,700 @ $130.80 ($1,007,177); 600 @ $131.34 ($78,806). Total ~15,000 shares / ~$1.95M.
• Footnote F1: Transactions made pursuant to a Rule 10b5-1 trading plan adopted Feb 25, 2026.
• Footnotes F2–F4: Reported sale-price ranges across the blocks ($129.17–$131.47); detailed per-price allocations are available from the SEC/issuer/shareholders on request.
• Shares owned after the transaction: not specified in the provided filing excerpt — see the full SEC filing for post-transaction holdings.
• Transaction code: S = Sale.

Context
These sales were executed under a pre-established Rule 10b5-1 plan, which allows insiders to sell shares according to a preset schedule and can limit the informational value of the timing. The filing is a disposition (sale), which is generally viewed as routine insider liquidity rather than a direct signal about company fundamentals. For full details (including exact holdings after the trades or a per-price breakdown), consult the complete Form 4 available on the SEC EDGAR site.